Src
Src inhibitors are compounds that target Src family kinases, which are involved in various cellular processes, including growth, differentiation, and angiogenesis. Src kinases play a critical role in the signaling pathways that promote the formation of new blood vessels in tumors. Inhibiting Src can disrupt these pathways, thereby reducing angiogenesis and tumor growth. Src inhibitors are widely used in cancer research and therapeutic development. At CymitQuimica, we provide a comprehensive selection of high-quality Src inhibitors to support your research in oncology, cell signaling, and angiogenesis.
Found 82 products of "Src"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
NVP-BHG 712
CAS:Formula:C26H20F3N7OPurity:>95.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:503.49Dasatinib
CAS:Formula:C22H26ClN7O2SPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:488.01Dasatinib
CAS:Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive.Formula:C22H26ClN7O2SPurity:99.59% - 99.86%Color and Shape:Pale-Yellow SolidMolecular weight:488.01Bosutinib
CAS:Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.Formula:C26H29Cl2N5O3Purity:98.98% - 99.9%Color and Shape:Yellowish-Orange Or Pink To Brownish Solid Solid PowderMolecular weight:530.45Dasatinib monohydrate
CAS:Dasatinib monohydrate, an oral SRC-kinase inhibitor, counters imatinib-resistant chronic myeloid leukemia.Formula:C22H28ClN7O3SPurity:99.68% - >99.99%Color and Shape:SolidMolecular weight:506.03Tirbanibulin Mesylate
CAS:Tirbanibulin Mesylate (KX01 Mesylate) is an inhibitor of Src that targets the peptide substrate site of Src (GI50: 9-60 nM in cancer cell lines).Formula:C27H33N3O6SPurity:99%Color and Shape:SolidMolecular weight:527.63Ref: TM-T15675
2mg35.00€5mg52.00€10mg66.00€25mg119.00€50mg230.00€100mg394.00€200mg532.00€1mL*10mM (DMSO)62.00€Hck-IN-1
CAS:Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; >20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.Formula:C16H11ClN6O3SPurity:99.07%Color and Shape:SolidMolecular weight:402.81Ref: TM-T11538
1mg62.00€5mg128.00€10mg197.00€25mg323.00€50mg469.00€100mg637.00€1mL*10mM (DMSO)141.00€CSF1R-IN-2
CAS:CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).Formula:C20H20FN7O2Purity:99.29%Color and Shape:SolidMolecular weight:409.42Ref: IN-DA00AP0L
1gTo inquire1mg27.00€5mg67.00€10mg81.00€25mg110.00€50mg126.00€100mg193.00€250mg273.00€Adrenalone hydrochloride
CAS:Adrenalone HCl: α1-adrenoceptor agonist, topical hemostatic, vasoconstrictor, prolongs local anesthesia.Formula:C9H11NO3·HClPurity:99.94%Color and Shape:SolidMolecular weight:217.65N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide
CAS:Phosphopeptide; binds to the src SH2 domain.Formula:C26H42N3O9PPurity:98%Color and Shape:SolidMolecular weight:571.61Osteogenic Growth Peptide (10-14) acetate
Osteogenic Growth Peptide (10-14) acetate (Osteogenic Growth Peptide) is a Src inhibitor and an effective mitogen and stimulator of osteogenesis andFormula:C26H33N5O9Purity:98.69%Color and Shape:SolidMolecular weight:559.57Ref: TM-T37603L
1mg205.00€2mg358.00€5mg515.00€10mg737.00€25mg1,125.00€50mg1,521.00€100mg2,052.00€1mL*10mM (DMSO)695.00€LCB 03-0110 dihydrochloride
CAS:LCB 03-0110 Dihydrochloride is a potent inhibitor of the c-Src kinase (IC50 = 1.3 nM) and tyrosine kinases in the BTK and SYK family, as well as in the DDR2Formula:C24H25Cl2N3O2SPurity:99.9%Color and Shape:SoildMolecular weight:490.45Ref: TM-T32613
1mg73.00€2mg99.00€5mg152.00€10mg215.00€25mg358.00€50mg512.00€100mgTo inquire1mL*10mM (DMSO)178.00€Secretin, canine
CAS:Secretin: endocrine hormone, increases bicarbonate-rich pancreatic fluid, regulates canine gastric functions via Src kinase pathway.Formula:C131H222N44O41Purity:98%Color and Shape:SolidMolecular weight:3069.43pYEEI
pYEEI, a tetrapeptide containing phosphotyrosine, binds to the SrcSH2 domain with a dissociation constant (Kd) of 100 nM and an inhibitory concentration (IC50) of 6.5 μM. This compound plays a crucial role in cancer research.Formula:C25H36N3O14PColor and Shape:SolidMolecular weight:633.54Tyrosine Kinase Inhibitor Library
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase relatedColor and Shape:Odour SolidRef: TM-L2200
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireKinase Inhibitor Library
A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;Color and Shape:Odour SolidRef: TM-L1600
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireCaffeic acid-pYEEIE
CAS:Phosphopeptide ligand for the src SH2 domain (IC50 = 42 nM); displays 30-fold higher affinity than N-acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu (Ac-pYEEIE,).
Formula:C39H50N5O19PPurity:98%Color and Shape:SolidMolecular weight:923.82Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH
CAS:Phosphopeptide ligand for the src SH2 domain (IC50 = 1 μM). Blocks src interactions with EGFR and FAK.Formula:C32H46N5O17PPurity:98%Color and Shape:SolidMolecular weight:803.71
